Gastrointestinal Cancer CPG Mini-Module – Management of lower gastrointestinal tumors

The SITC Cancer Immunotherapy Guidelines Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the clinical practice guidelines. To complement the advanced live webinar series, these on-demand, mini modules will assist learners in applying lessons learned on specific topics within the use of immunotherapy in their own practices and locate additional resources to continue their education.   

Cathy Eng, MD, FACP, FASCO, of Vanderbilt-Ingram Cancer Center, addresses the guidelines in the context of tumors in the lower gastrointestinal tract by presenting a case study of multidisciplinary management of metastatic colorectal cancer. Dr. Eng also discusses important considerations when deciding between single-agent immune checkpoint blockade or combination therapy and the clinical data underlying these considerations.

Run time: Approximately 15 minutes

Target Audience
Clinicians and advanced practice providers who treat cancer patients are the target audience, including community physicians, oncologists, emergency room physicians, disease specialists, registered nurses, nurse practitioners, pharmacists, physician assistants and radiologists. 

SITC Online Education Disclaimer 

A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. 

The Quick Education Modules are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 09/07/2023). 

The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.